These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Inappropriately high plasma leptin levels in obese haemodialysis patients can be reduced by high flux haemodialysis and haemodiafiltration. Wiesholzer M; Harm F; Hauser AC; Pribasnig A; Balcke P Clin Sci (Lond); 1998 Apr; 94(4):431-5. PubMed ID: 9640349 [TBL] [Abstract][Full Text] [Related]
27. Intravenous N-acetylcysteine during haemodialysis reduces the plasma concentration of homocysteine in patients with end-stage renal disease. Thaha M; Yogiantoro M; Tomino Y Clin Drug Investig; 2006; 26(4):195-202. PubMed ID: 17163251 [TBL] [Abstract][Full Text] [Related]
28. Effect of permeability on indices of haemodialysis membrane biocompatibility. Masaki T; Gilson J; Leypoldt JK; Cheung AK Nephrol Dial Transplant; 1999 May; 14(5):1176-81. PubMed ID: 10344358 [TBL] [Abstract][Full Text] [Related]
29. Procalcitonin for accurate detection of infection in haemodialysis. Herget-Rosenthal S; Marggraf G; Pietruck F; Hüsing J; Strupat M; Philipp T; Kribben A Nephrol Dial Transplant; 2001 May; 16(5):975-9. PubMed ID: 11328903 [TBL] [Abstract][Full Text] [Related]
30. Influence of dialysis modality and membrane flux on insomnia severity in haemodialysis patients. Knezevic MZ; Djordjevic VV; Jankovic SM; Djordjevic VM Nephrology (Carlton); 2013 Nov; 18(11):706-11. PubMed ID: 23848433 [TBL] [Abstract][Full Text] [Related]
31. Cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease. Macleod AM; Campbell M; Cody JD; Daly C; Donaldson C; Grant A; Khan I; Rabindranath KS; Vale L; Wallace S Cochrane Database Syst Rev; 2005 Jul; 2005(3):CD003234. PubMed ID: 16034894 [TBL] [Abstract][Full Text] [Related]
32. Relative importance of residual renal function and convection in determining beta-2-microglobulin levels in high-flux haemodialysis and on-line haemodiafiltration. Fry AC; Singh DK; Chandna SM; Farrington K Blood Purif; 2007; 25(3):295-302. PubMed ID: 17622712 [TBL] [Abstract][Full Text] [Related]
33. Enhanced long-term reduction of plasma leptin concentrations by super-flux polysulfone dialysers. van Tellingen A; Grooteman MP; Schoorl M; ter Wee PM; Bartels PC; Schoorl M; van der Ploeg T; Nubé MJ Nephrol Dial Transplant; 2004 May; 19(5):1198-203. PubMed ID: 14993491 [TBL] [Abstract][Full Text] [Related]
34. Effect of high-flux dialysis on the anaemia of haemodialysis patients. Locatelli F; Andrulli S; Pecchini F; Pedrini L; Agliata S; Lucchi L; Farina M; La Milia V; Grassi C; Borghi M; Redaelli B; Conte F; Ratto G; Cabiddu G; Grossi C; Modenese R Nephrol Dial Transplant; 2000 Sep; 15(9):1399-409. PubMed ID: 10978398 [TBL] [Abstract][Full Text] [Related]
36. Impact of low- or high-flux haemodialysis and online haemodiafiltration on inflammatory markers and lipid profile in chronic haemodialysis patients. Akoglu H; Dede F; Piskinpasa S; Falay MY; Odabas AR Blood Purif; 2013; 35(4):258-64. PubMed ID: 23689379 [TBL] [Abstract][Full Text] [Related]
37. Influence of dialysis procedure, membrane surface and membrane material on iopromide elimination in patients with reduced kidney function. Matzkies FK; Reinecke H; Tombach B; Kosch M; Hegger K; Milius M; Hohage H; Kisters K; Kerber S; Schaefer RM Am J Nephrol; 2000; 20(4):300-4. PubMed ID: 10970983 [TBL] [Abstract][Full Text] [Related]
38. High-flux synthetic versus cellulosic membranes for beta 2-microglobulin removal during hemodialysis, hemodiafiltration and hemofiltration. Floege J; Granolleras C; Deschodt G; Heck M; Baudin G; Branger B; Tournier O; Reinhard B; Eisenbach GM; Smeby LC Nephrol Dial Transplant; 1989; 4(7):653-7. PubMed ID: 2510064 [TBL] [Abstract][Full Text] [Related]
39. Effects of membrane characteristics on cytokine production by mononuclear cells in regular haemodialysis patients. Kino K; Akizawa T; Koshikawa S Nephrol Dial Transplant; 1995; 10 Suppl 3():29-33. PubMed ID: 7494611 [TBL] [Abstract][Full Text] [Related]
40. Effect of dialyser membrane pore size on plasma homocysteine levels in haemodialysis patients. De Vriese AS; Langlois M; Bernard D; Geerolf I; Stevens L; Boelaert JR; Schurgers M; Matthys E Nephrol Dial Transplant; 2003 Dec; 18(12):2596-600. PubMed ID: 14605283 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]